California-based biotechnology organization Ardea Biosciences tadalafil online.

AstraZeneca completes acquisition of Ardea Biosciences Today announced that on Tuesday 19 June 2012 it completed its acquisition of NORTH PARK AstraZeneca, California-based biotechnology organization Ardea Biosciences, Inc. The merger was authorized by Ardea’s stockholders. Upon completion of the merger, each excellent talk about of Ardea common share was cancelled and changed into the right to get $32 tadalafil online .00, in cash, without curiosity, and shares of Ardea common share ceased trading on the NASDAQ Global Choose Market. As announced previously, the acquisition strengthens AstraZeneca’s late-stage pipeline with the help of lesinurad, a potential next-era treatment for the chronic administration of hyperuricaemia in individuals with gout pain.

Random entries

Other entries from category "transplantation":